Our study also reports that Vigeo inhibited arthritis symptoms, including bone loss and serum levels of TNF-α, IL-6, and IL-1β, in a mouse model of collagen-induced arthritis/rheumatoid arthritis [39]. This evidence concerns the gene TNF and arthritic joint disease.